Beyond randomized controlled trials: A critical comparison of trials with nonrandomized studies
Henrik Toft Sørensen, Timothy Lee Lash, Kenneth Jay Rothman · Hepatology · 2006
Observational analogs of randomized clinical trials (RCTs) are well accepted in the study of disease risk factors, diagnosis, and prognosis. There is controversy about observational studies when the focus is on the intended benefit due to lack of blinding and poor control for unmeasured confounding. Well-designed randomized clinical trials are costly both in time and money. Therefore, existing databases are used increasingly and are often the only feasible source with which to examine delayed health effects. We reviewed the reasons for possible discrepancies between RCTs and observational studies. There can be different patient populations, differences in therapeutic regimen, control of confounding, follow-up, measuring outcome, and differences arising from the intention-to-treat analysis. Observational studies cannot replace trials, nor do trials make observational studies unnecessary. Both designs are susceptible to particular bias, so neither provides perfect information.
Cited by 236 works. doi:10.1002/hep.21404 Open-access PDF
Authors
References
- Clinical Epidemiology: A Basic Science for Clinical Medicine.
- Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
- Clinical Epidemiology: The Essentials.
- A Comparison of Observational Studies and Randomized, Controlled Trials
- Epidemiology: An introduction
- Participation in Cancer Clinical Trials
- Evaluating Medication Effects Outside of Clinical Trials: New-User Designs
- Comparison of Evidence of Treatment Effects in Randomized and Nonrandomized Studies
- Treatment adherence and risk of death after a myocardial infarction
- A review of uses of health care utilization databases for epidemiologic research on therapeutics